RTSN
Retension Pharmaceuticals
$13.09
−$0.43 (−3.18%)Oct 28, 2026
Key metrics
The numbers that frame RTSN today
- Market cap
- $103.17M
- Div yield
- 0%
Growth
Revenue and earnings trend for RTSN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RTSN
What is the market capitalization of RTSN?
Retension Pharmaceuticals's market capitalization is $103.17M.
Does RTSN stock pay dividends?
Retension Pharmaceuticals does not currently show a dividend per share in the company data.